Novel peptide approach reduces chronic neuropathic pain in mice
News-Medical reports on Boston Children's Hospital research in mice, published in Cell Reports Medicine, finding that a short lipidated peptide disrupting the interaction between the NaV 1.8 sodium channel and the scaffolding protein ankyrin-G quieted hyperexcitable pain-sensing neurons and reduced pain-like behaviors in mouse models while sparing acute protective pain. The work is preclinical and has been licensed to Mimetic Medicines for investigational development.
Why it matters: Relevant to Maryland clinicians and rehabilitation readers following early preclinical research into non-opioid approaches to chronic neuropathic pain.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to news-medical.net. October 6, 2026.